|
|
Blood, 15 January 2004, Vol. 103, No. 2, pp. 562-570.
Prepublished online as a Blood First Edition Paper on September 22, 2003; DOI 10.1182/blood-2003-06-2109.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
VWRPY motif–dependent and –independent roles of AML1/Runx1 transcription factor in murine hematopoietic development
Motohiro Nishimura,
Yoko Fukushima-Nakase,
Yasuko Fujita,
Mitsushige Nakao,
Shogo Toda,
Nobuo Kitamura,
Tatsuo Abe, and
Tsukasa Okuda
From the Departments of Hygiene, Thoracic Surgery, Pediatrics, and Hematology/Oncology, Kyoto Prefectural University of Medicine, Japan.
AML1/Runx1 is a frequent target of leukemia-associated gene aberration, and it encodes a transcription factor essential for definitive hematopoiesis. We previously reported that the AML1 molecules with trans-activation subdomains retained can rescue in vitro hematopoietic defects of AML1-deficient mouse embryonic stem (ES) cells when expressed by using a knock-in approach. Extending this notion to in vivo conditions, we found that the knock-in ES cell clones with AML1 mutants, which retain trans-activation subdomains but lack C-terminal repression subdomains including the conserved VWRPY motif, contribute to hematopoietic tissues in chimera mice. We also found that germline mice homozygous for the mutated AML1 allele, which lacks the VWRPY motif, exhibit a minimal effect on hematopoietic development, as was observed in control knock-in mice with full-length AML1. On the other hand, reduced cell numbers and deviant CD4 expression were observed during early T-lymphoid ontogeny in the VWRPY-deficient mice, whereas the contribution to the thymus by the corresponding ES cell clones was inadequate. These findings demonstrate that AML1 with its trans-activating subdomains is essential and sufficient for hematopoietic development in the context of the entire mouse. In addition, its trans-repression activity, depending on the C-terminal VWRPY motif, plays a role in early thymocyte development.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
R. Setoguchi, M. Tachibana, Y. Naoe, S. Muroi, K. Akiyama, C. Tezuka, T. Okuda, and I. Taniuchi
Repression of the Transcription Factor Th-POK by Runx Complexes in Cytotoxic T Cell Development
Science,
February 8, 2008;
319(5864):
822 - 825.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Liu, F.-C. Yang, T. Okuda, X. Dong, M. J. Zylka, C.-L. Chen, D. J. Anderson, R. Kuner, and Q. Ma
Mechanisms of Compartmentalized Expression of Mrg Class G-Protein-Coupled Sensory Receptors
J. Neurosci.,
January 2, 2008;
28(1):
125 - 132.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Zhao, J. L. Cannons, S. Anderson, M. Kirby, L. Xu, L. H. Castilla, P. L. Schwartzberg, R. Bosselut, and P. P. Liu
CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus
Blood,
April 15, 2007;
109(8):
3432 - 3440.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Yarmus, E. Woolf, Y. Bernstein, O. Fainaru, V. Negreanu, D. Levanon, and Y. Groner
Groucho/transducin-like Enhancer-of-split (TLE)-dependent and -independent transcriptional regulation by Runx3
PNAS,
May 9, 2006;
103(19):
7384 - 7389.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Fukushima-Nakase, Y. Naoe, I. Taniuchi, H. Hosoi, T. Sugimoto, and T. Okuda
Shared and distinct roles mediated through C-terminal subdomains of acute myeloid leukemia/Runt-related transcription factor molecules in murine development
Blood,
June 1, 2005;
105(11):
4298 - 4307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-I. Trompeter, N. Gomez-Lozano, S. Santourlidis, B. Eisermann, P. Wernet, C. Vilches, and M. Uhrberg
Three Structurally and Functionally Divergent Kinds of Promoters Regulate Expression of Clonally Distributed Killer Cell Ig-Like Receptors (KIR), of KIR2DL4, and of KIR3DL3
J. Immunol.,
April 1, 2005;
174(7):
4135 - 4143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kawazu, T. Asai, M. Ichikawa, G. Yamamoto, T. Saito, S. Goyama, K. Mitani, K. Miyazono, S. Chiba, S. Ogawa, et al.
Functional Domains of Runx1 Are Differentially Required for CD4 Repression, TCR{beta} Expression, and CD4/8 Double-Negative to CD4/8 Double-Positive Transition in Thymocyte Development
J. Immunol.,
March 15, 2005;
174(6):
3526 - 3533.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Goyama, Y. Yamaguchi, Y. Imai, M. Kawazu, M. Nakagawa, T. Asai, K. Kumano, K. Mitani, S. Ogawa, S. Chiba, et al.
The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region
Blood,
December 1, 2004;
104(12):
3558 - 3564.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
